Phathom Pharmaceuticals, Inc.
corporate_fare Company Profile
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for PHAT at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Major Investor Frazier Life Sciences Files to Liquidate Entire 8.2% Stake Near 52-Week Highs
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$175.11M
Net Income
-$221.25M
Diluted EPS
-$3.03
Op. Cash Flow
-$166.78M
Free Cash Flow
-$167M
Gross Profit
$152.51M
Operating Income
-$159.99M
Cash & Equivalents
$129.97M
Total Debt
$209.09M
Debt / Equity
-0.48×
Net Margin
-126.3%
Shares Outstanding
71.42M sh
Source: 10-K · filed 2026-02-26 · accession 0001193125-26-073379
show_chartPrice Chart
Loading chart...
feed PHAT - Filings & News (Page 2)
PHAT
Jan 07, 2026, 4:01 PM EST
Price at Filing:
$18.16
Real-time Price:
$4.66
Change:
-$13.50 (-74%)
Market Cap:
$378.819M